ClinicalTrials.Veeva

Menu

Reliability and Validity of Outcome Measures for Pain in Multiple Sclerosis

H

Hasselt University

Status

Completed

Conditions

Pain

Study type

Observational

Funder types

Other

Identifiers

NCT05742152
B1152022000014

Details and patient eligibility

About

This project aims to provide values of test-retest reliability and insights from concurrent validity of outcome measures for pain in multiple sclerosis.

Full description

Pain is one of the most annoying symptoms in multiple sclerosis (MS). However, it is underestimated albeit its high prevalence rate with 63%. It negatively affects health related quality of life, activity of daily living, mental health, social functioning, employment, sleep and life enjoyment. In literature, the prevalence of pain varies in the MS literature from 29% to 86%. This wide-range prevalence is the result of methodological differences and non-uniformity of the studied populations which makes pain unclear and underdiagnosed in multiple sclerosis.It is hypothesized that the consistency, severity and interference of pain have varying relationships between other factors such as depression, anxiety, sleep or fatigue.

Evaluating pain was done with various outcome measures resulting in inconclusive results. However, very few of the pain outcome measures are validated for MS population. Thus, it cannot be advised yet whether they contain similar or complementary information. Finally, the interference of pain on activities and participation level of the International Classification of Functioning, Disability and Health (ICF) is poorly documented.

This project aims to put the foundations for future interventional research by providing values of test-retest reliability and insights from concurrent validity. As well, the perceived interference from pain on activities and participation level will be documented.

Enrollment

60 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 and above,
  • Ambulatory pwMS with definite diagnosis based on McDonald criteria
  • Expanded Disability Status Scale of 6.0 or below,
  • Having pain in last month
  • Able to understand and answer the questions in the questionnaires.

Exclusion criteria

  • Diagnosed with major musculoskeletal disorder and any neurological disorder other than MS,
  • a relapse in the last month before enrolment,
  • cognitive decline that renders the patient incapable of performing tests and questionnaires,
  • patients with only headache

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems